Category: Vet Pharmacological Index

Tablets

Composition:

1 tablet contains: Berberis vulgaris D2 15 mg; Lytta vesicatoria D5, Plumbum aceticum D6, Serenoa repens D2 30 mg each; Causticum Hahnemanni D4 60 mg; Aluminium oxydatum D12 75 mg.

Indications:

Inflammatory diseases of the urinary passages with or without lithiasis.

Contraindications: None known.

Side effects: None known.

Interaction with other medications: None known.

Dosage:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Therapeutic applications:

Owing to the individual homeopathic constituents of this medication, therapeutical possibilities result for the treatment of inflammatory disorders in the region of the uri- nary passages, with or without lithiasis, e.g. cystitis, cystopyelitis, nephrolithiasis.

Package sizes:

Packs containing 50 and 250 tablets

Injection Solution 1.1 ml

Drops

Composition:

Injection solution: 1.1 ml cont.: Psorinum-Nosode D10, Medorrhinum-Nosode D12, Sulfur D6, Thuja occidentalis D6, Bufo bufo D10, Natrium chloratum D12, Vaccininum- Nosode D8 1.10 mg each; Bismutum kalium iodidum D5, Nerium oleander D4, Cicuta virosa D5, Bacillinum-Nosode D12 0.55 mg each.

Drops: 100 g cont.: Psorinum-Nosode D10, Medorrhinum-Nosode D12, Sulfur D6, Thuja occidentalis D6, Bufo bufo D10, Natrium chloratum D12, Vaccininum-Nosode D8 10.0 g each; Bismutum kalium iodidum D5, Nerium oleander D4, Cicuta virosa D5, Bacillinum-Nosode D12 5.0 g each. Contains 35 vol.-% alcohol.

Indications:

Stimulation (reversal) therapy for skin disorders, hepatic damage, and for chronic ill- nesses in general.

Contraindications: None known.

Side effects: None known.

Interaction with other medications: None known.

Dosage:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Injection solution: Packs containing 10 or 50 ampoules of 1.1 ml each. Drops: Drop bottles containing 30 or 100 ml.

Drops

Composition:

100 g cont.: Populus tremuloides Ø, Sabal serrulatum Ø 10 g each; Capsicum annuum D3, Bucco D3, Orthosiphon aristatus D3, Piper cubeba D3, Camphora D3, Apis melli- fica D3, Solidago virgaurea D3, Scrophularia nodosa D3, Ononis spinosa D3, Petroseli- num crispum D3, Cucurbita pepo D3, Baptisia tinctoria D3, Arctostaphylos uva-ursi D3, Scilla D3, Equisetum hyemale D3, Urtica urens D3, Kreosotum D5, Berberis vulgaris D5, Cantharis D5, Mercurius sublimatus corrosivus D8, Terebinthina laricina D6 3 g each. Contains 80 vol.-% alcohol.

Indications:

Stimulation of the defense system in disturbance of the renal function and excretion, albuminaria, irritation in the urinary system, cystopyelitis, cystitis, hydronephrosis, nephrolithiasis, (as additional medication in bacteriuria) and particularly in micturition disorders (1st stage of prostatic adenoma).

Contraindications: In case of hypersensitivity to Solidago or to other composites Popu- lus compositum SR must not be used. Bee venom hypersensitivity.

Side effects: Hypersalivation may occur upon administration, in which case use of the product should be discontinued. Phenol allergy. Allergic reactions or hypersalivation may occur on account of the homeopathic active substance Hydrargyrum bichloratum (mercury). The medication should then be withdrawn and a doctor should be consul- ted.

Interaction with other medications: None known.

Dosage:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Drop bottles containing 30 or 100 ml.

Phosphor-Homaccord® ad us. vet. Injection Solution 5.0 ml

Phosphor-Homaccord® Drops

Composition:

1 ampoule of 5.0 ml contains: Phosphorus D10 0.02 ml; Phosphorus D30 0.02 ml; Phosphorus D200 0.02 ml; Argentum nitricum D10 0.015 ml; Argentum nitricum D30

0.015 ml; Argentum nitricum D200 0.015 ml; Paris quadrifolia D6 0.015 ml; Paris quadrifolia D10 0.015 ml; Paris quadrifolia D30 0.015 ml; Paris quadrifolia D200

0.015 ml.

Drops: 100 g cont.: Phosphorus D10, Phosphorus D30, Phosphorus D200 0.4 g each; Argentum nitricum D10, Argentum nitricum D30, Argentum nitricum D200, Paris qua- drifolia D6, Paris quadrifolia D10, Paris quadrifolia D30, Paris quadrifolia D200 0.3 g each. Contains 35 vol.-% alcohol.

Indications:

Affections of parenchymatous organs, hemorrhagic diathesis, disorders of the nutritive organs, rachitis, osteomalacia, tetany, bronchopneumonia, pharyngitis, chronic udder diseases, skin diseases, neurosis, behavioral disorders.

Contraindications: None known.

Side effects: None known.

Interaction with other medications: None known.

Waiting period: None.

Instructions for use, route and duration of administration:

Phosphor-Homaccord ad us. vet. is to be administered by s.c., i.m. or i.v. injection.

According to species, the single dosage is as follows:

Horse, cattle, swine: 5 ml

Piglet: 2–3 ml

Sheep, goat: 2 ml

Large dog: 3–4 ml

Medium dog: 2 ml

Small dog, cat: 1–2 ml

Puppy: 0.5–1 ml

Small pets: 0.5 ml

If necessary, depending on the severity of the case, the indicated dosage is to be re- peated after 24 hours.

For treatment of disorders with tendencies to recur, chronic affections or long-term treatment, the indicated single dosage can be administered at 4-day intervals.

Dosage: Phosphor-Homaccord drops:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Packs containing 5 or 50 ampoules of 5.0 ml each. Drop bottles containing 30 or 100 ml.

Ovarium compositum ad us. vet. Injection Solution 5.0 ml

Ovarium compositum Injection Solution 2.2 ml

Composition:

Ovarium compositum ad us. vet.: 1 ampoule of 5 ml contains: Ovarium suis D8; Pla- centa suis D10; Uterus suis D10; Salpinx suis D10; Hypophysis suis D13; Cypripedium calceolus var. pubescens D6; Lilium tigrinum D4; Pulsatilla pratensis D18; Aquilegia vulgaris D4; Sepia officinalis D10; Lachesis mutus D10; Apisinum D8; Kreosotum D8; Bovista D6; Ipecacuanha D6; Mercurius solubilis Hahnemanni D10l; Hydrastis canaden- sis D4; Acidum cis-aconiticum D10; Magnesium phosphoricum D10 0.05 ml each.

Ovarium compositum: 1 ampoule of 2.2 ml (= 2.2 g) contains: Ovarium suis D8, Pla- centa suis D10, Uterus suis D10, Salpinx suis D10, Hypophysis suis D13, Cypripedium calceolus var. pubescens D6, Lilium tigrinum D4, Pulsatilla pratensis D18, Aquilegia

vulgaris D4, Sepia officinalis D10, Lachesis mutus D10, Apisinum D8, Kreosotum D8, Bovista D6, Ipecacuanha D6, Mercurius solubilis Hahnemanni D10, Hydrastis canaden- sis D4, Acidum cis-aconiticum D10, Magnesium phosphoricum D10 22 µl each.

Indications:

Disorders of the ovarian cycle, infertility due to degenerative changes or dysfunctions of the ovaries, large and small cystic degeneration of the ovaries, endometritis, stimu- lation of the functions of glands and connective tissue in elder animals.

Contraindications: None known.

Side effects: Hypersalivation may occur upon administration, in which case use of the product should be discontinued. Allergic reactions may occasionally occur on account of the homeopathic active substance Mercurius solubilis.

Interaction with other medications: None known.

Waiting period: None.

Instructions for use, route and duration of administration:

Ovarium compositum ad us. vet. is to be administered by s.c. or i.v. injection.

According to species, the daily single dosage is as follows:

Horse, cattle, swine: 5 ml

Sheep, goat: 2 ml

Large dog: 3–4 ml

Medium dog: 2 ml

Small dog, cat: 1–2 ml

Small pets: 0.5 ml

The indicated dosage can be repeated after a period of 8 days.

Dosage: Ovarium compositum injection solution 2.2 ml:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Ovarium compositum ad us. vet.: Packs containing 5 or 50 ampoules of 5.0 ml each. Ovarium compositum: Packs containing 10 or 50 ampoules of 2.2 ml each.

Tablets

Composition:

1 tablet contains: Hekla-Lava D6, Kalium jodatum D4, Asa foetida D4, Stillingia sylva- tica D4, Araneus diadematus D6, Natrium sulfuricum D4 30 mg each; Mercurius prae- cipitatus ruber D9, Calcium phosphoricum D6 60 mg each.

Indications:

Diseases of the bones, cartilage and connective tissue. Exostosis, especially in foals and during growth in large breeds of dogs. Actinomycosis, tibia disorders in racehorses, bone fistulae. Rickets.

Contraindications: Do not use in thyroid disorders without seeking medical advice.

Side effects: Hypersalivation may occur upon administration, in which case use of the product should be discontinued.

Interaction with other medications: None known.

Dosage:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Packs containing 50 and 250 tablets.

Eye Drops – Single-dose phial 0.45 ml

Composition:

1 phial with 0.45 ml (= 0.45 g) contains: Euphrasia officinalis D5 110.7 mg, Cochlearia officinalis D5 110.7 mg, Jaborandi D5 110.7 mg, Echinacea angustifolia D5 110.7 mg. Other constituents: sodium chloride, sodium dihydrogen phosphate dihydrate, Diso- dium phosphate dihydrate.

Indications:

Irritation and inflammation of the conjunctiva and marginal eyelid due to external stim- uli, overstraining, or allergic reactions; dry eyes.

Contraindications: Hypersensitivity to one of the active ingredients or excipients or to plants of the daisy (compositae) family.

Side effects: Hypersensitivity reactions may occur in individual cases. Local allergic reactions (cutaneous inflammation) have been reported.

Interaction with other medications: None known.

Instructions for use, route and duration of administration:

Drip eye drops 1 to 3 times daily into the lower conjunctival sac until the symptoms disappear.

Dog, cat: 1–3 drops in each eye

Small domestic rodent:1–2 drops in each eye

For acute conditions, the dose can initially be repeated every hour for up to 6 times daily. Do not open the phial until just before application. Discard any phial which may still contain solution, and do not use later.

Protect from heat.

Do not store above 30 °C.

Package sizes:

15 phials with 0.45 ml.

Composition:

Nux vomica-Homaccord ad us. vet.: 1 ampoule of 5 ml (= 5 g) contains: Strychnos nux- vomica D4, Strychnos nux-vomica D10, Strychnos nux-vomica D15, Strychnos nux- vomica D30, Strychnos nux-vomica D200, Strychnos nux-vomica D1000 10 mg each; Bryonia D4, Bryonia D6, Bryonia D10, Bryonia D15, Bryonia D30, Bryonia D200, Bryo- nia D1000 10 mg each; Lycopodium clavatum D5, Lycopodium clavatum D10, Lycopo- dium clavatum D30, Lycopodium clavatum D200, Lycopodium clavatum D1000 15 mg each; Citrullus colocynthis D5, Citrullus colocynthis D10, Citrullus colocynthis D30, Citrullus colocynthis D200 15 mg each.

Nux vomica-Homaccord: 1 ampoule of 1.1 ml (= 1.1 g) contains: Strychnos nux-vomica D4, Strychnos nux-vomica D10, Strychnos nux-vomica D15, Strychnos nux-vomica D30, Strychnos nux-vomica D200, Strychnos nux-vomica D1000, Bryonia D4, Bryonia D6, Bryonia D10, Bryonia D15, Bryonia D30, Bryonia D200, Bryonia D1000

2.2 mg each; Lycopodium clavatum D5, Lycopodium clavatum D10, Lycopodium clava- tum D30, Lycopodium clavatum D200, Lycopodium clavatum D1000, Citrullus colo- cynthis D5, Citrullus colocynthis D10, Citrullus colocynthis D30, Citrullus colocynthis D200 3.3 mg each.

Nux vomica-Homaccord drops: 100 g cont.: Strychnos nux-vomica D2, Strychnos nux- vomica D10, Strychnos nux-vomica D15, Strychnos nux-vomica D30, Strychnos nux- vomica D200, Strychnos nux-vomica D1000, Bryonia D2, Bryonia D6, Bryonia D10, Bryonia D15, Bryonia D30, Bryonia D200, Bryonia D1000 0.2 g each; Lycopodium cla- vatum D3, Lycopodium clavatum D10, Lycopodium clavatum D30, Lycopodium clava- tum D200, Lycopodium clavatum D1000, Citrullus colocynthis D3, Citrullus colocynthis D10, Citrullus colocynthis D30, Citrullus colocynthis D200 0.3 g each. Contains 35 vol.-% alcohol.

Indications:

Dysfunctions in the gastrointestinal and liver system, spastic processes of the alimen- tary tract with restlessness, colic, acute and chronic gastroenteritis, obstipation with spasms, slipped discs, meteorism.

Contraindications: None known.

Side effects: None known.

Interaction with other medications: None known.

Waiting period: None.

Instructions for use, route and duration of administration:

Nux vomica-Homaccord ad us. vet. is to be administered by s.c., i.m. or i.v. injection.

According to species, the single dosage is as follows:

Horse, cattle, swine: 5 ml

Piglet: 2–3 ml

Sheep, goat: 2 ml

Large dog: 3–4 ml

Medium dog: 2 ml

Small dog, cat: 1–2 ml

Puppy: 0.5–1 ml

Small pets: 0.5 ml

If necessary, depending on the severity of the case, the indicated dosage is to be re- peated after 12 or 24 hours.

For treatment of disorders with tendencies to recur, chronic affections or long-term treatment, the indicated single dosage can be administered at 4-day intervals.

Dosage: Nux vomica-Homaccord injection solution 1.1 ml, Nux vomica-Homaccord drops:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Nux vomica-Homaccord ad us. vet. injection solution: Packs containing 5 or 50 am- poules of 5.0 ml each.

Nux vomica-Homaccord injection solution: Packs containing 10 or 50 ampoules of

1.1 ml each.

Nux vomica-Homaccord drops: Drop bottles containing 30 or 100 ml.

Mucosa compositum ad us. vet. Injection Solution 5.0 ml

Mucosa compositum Heel Injection Solution 2.2 ml

Composition:

Mucosa compositum ad us. vet.: 1 ampoule of 5.0 ml contains: Mucosa nasalis suis D8; Mucosa oris suis D8; Mucosa pulmonis suis D8; Mucosa oculi suis D8; Mucosa vesicae felleae suis D8; Mucosa pylori suis D8; Mucosa duodeni suis D8; Mucosa oesophagi suis D8; Mucosa jejuni suis D8; Mucosa ilei suis D8; Mucosa coli suis D8; Mucosa recti suis D8; Mucosa ductus choledochi suis D8; Mucosa vesicae urinariae suis D8; Ventri- culus suis D8; Pankreas suis D10; Argentum nitricum D6; Atropa belladonna D10; Oxalis acetosella D6; Semecarpus anacardium D6; Phosphorus D8; Lachesis mutus D10; Ipecacuanha D8; Nux vomica D13; Veratrum album D4; Pulsatilla pratensis D6; Kreosotum D10; Sulfur D8; Bacterium coli-Nosode D28; Marsdenia cundurango D6; Kalium bichromicum D8; Hydrastis canadensis D4; Mandragora e radice siccato D10; Momordica balsamina D6; Ceanothus americanus D4; Natrium diethyloxalaceticum D8 0.05 ml each.

Mucosa compositum Heel: 1 ampoule of 2.2 ml (= 2.2 g) contains: Mucosa nasalis suis D8, Mucosa oris suis D8, Mucosa pulmonis suis D8, Mucosa oculi suis D8, Mucosa vesicae felleae suis D8, Mucosa vesicae urinariae suis D8, Mucosa pylori suis D8, Mucosa duodeni suis D8, Mucosa oesophagi suis D8, Mucosa jejuni suis D8, Mucosa ilei suis D8, Mucosa coli suis D8, Mucosa recti suis D8, Mucosa ductus choledochi suis D8, Ventriculus suis D8, Pankreas suis D10, Argentum nitricum D6, Atropa belladonna D10, Oxalis acetosella D6, Semecarpus anacardium D6, Phosphorus D8, Lachesis mutus D10, Cephaelis ipecacuanha D8, Strychnos nux-vomica D13, Veratrum album D4, Pulsatilla pratensis D6, Kreosotum D10, Sulfur D8, Natrium diethyloxalaceticum D8, Marsdenia cundurango D6, Kalium bichromicum D8, Hydrastis canadensis D4, Mandragora e radice siccato D10, Momordica balsamina D6, Ceanothus americanus D4 22 mg each.

Indications:

Mucosal disorders and catarrhs of different type and localisation, e. g. in the alimen- tary tract, upper and lower respiratory tract, uriniferous tract, conjunctiva of the eye, panleucopenia, Herpes-rhinovirus-infection, Parvovirus-infection, chronic enteritis, oti- tis, conjunctivitis, endometritis. Supportive to the specific therapy.

Contraindications: First trimenon of pregnancy.

Side effects: Skin reactions may occur in individual cases, in which case use of the product should be discontinued. Phenol allergy.

Interaction with other medications: None known.

Waiting period: None.

Instructions for use, route and duration of administration:

Mucosa compositum ad us. vet. is to be administered by s.c. or i.v. injection.

According to species, the daily single dosage is as follows:

Horse, cattle, swine: 5 ml

Piglet: 2–3 ml

Sheep, goat: 2 ml

Large dog: 3–4 ml

Medium dog: 2 ml

Small dog, cat: 1–2 ml

Puppy: 0.5–1 ml

Small pets: 0.5 ml

In cases with acute symptoms, the indicated dosage can be repeated after a period of 24 hours.

For treatment of disorders with tendencies to recur, chronic affections or long-term treatment, the indicated single dosage can be administered at 4-day intervals.

Dosage: Mucosa compositum Heel injection solution 2.2 ml:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Mucosa compositum ad us. vet.: Packs containing 5 or 50 ampoules of 5.0 ml each. Mucosa compositum Heel: Packs containing 10 or 50 ampoules of 2.2 ml each.

Tablets

Composition:

1 tablet cont.: Mercurius solubilis Hahnemanni D10 90 mg; Hepar sulfuris D8, Lachesis mutus D12, Phytolacca americana D4, Ailanthus altissima D3, Echinacea angustifolia D3 30 mg each; Atropa belladonna D4 60 mg.

Indications:

Furuncles, carbuncles and other suppurations, including, e.g. those in the (peri)-ton- sillar tissue.

Contraindications: Hypersensitivity to one of the active ingredients or excipients, or to plants of the composite family. As a matter of principle, Echinacea should not be used in progressive, systemic diseases such as tuberculosis, leukemia or leukemia-like dis- eases, inflammatory diseases of the connective tissue (collagen disease), autoimmune diseases, multiple sclerosis, AIDS, HIV infections or other chronic viral diseases.

Side effects: Hypersalivation may occur after administration, in which case the use of this product should be discontinued. Hypersensitivity reactions can occur in individual cases. Skin rash and itching (pruritus), and in rare cases facial swelling, shortness of breath (dyspnea), dizziness and a fall in blood pressure, have been observed after treatment with products containing Echinacea extracts. Allergic reactions may occa- sionally occur on account of the homeopathic active substance Mercurius solubilis, too.

Interaction with other medications: None known.

Dosage:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Packs containing 50 and 250 tablets.